This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Telling, G C Articles by Williams, J Search for Related Content PubMed PubMed Citation Articles by Telling, G C Articles by Williams, J

 Previous Article  |  Next Article 

J Virol. 1994 February; 68(2): 877-887

Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12.

Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.

ABSTRACT

The E1A gene of highly oncogenic type 12 adenovirus (Ad12) possesses a segment unique to this serotype and comprising 60 base pairs contiguous with and separating conserved regions 2 and 3 in the gene. A similar but slightly longer segment is also present in the E1A gene of highly oncogenic simian adenovirus type 7 (D. Kimelman, J. S. Miller, D. Porter, and B. E. Roberts, J. Virol. 53:399-409, 1985). This segment is missing entirely from the E1A gene of type 5 adenovirus, which is nononcogenic. To test the hypothesis that this unique separating or "spacer" region influences the oncogenicity of Ad12, we constructed ClaI and SmaI restriction sites on either side of it, which allowed reciprocal exchange between this and the equivalent cassette from type 5 adenovirus E1A, bounded by the same restriction sites intrinsic to that gene. The resultant Ad12-based chimeric viruses, ch702 and ch704, in which the spacer region is replaced with (in-frame) type 5 sequence, grow normally on human A549 cells and display wild-type transformation frequencies on baby rat and mouse kidney cells. In contrast, the oncogenic capacity of these chimeric viruses, as measured by tumor induction following virus inoculation in Hooded Lister rats, is greatly reduced. Likewise, cells transformed by ch702 and ch704 display reduced tumorigenicity compared with wild-type transformants in syngeneic rats. These results, coupled with recent preliminary tests using a mutant with a point mutation in this region, support the view that the unique spacer region of type 12 is an oncogenic determinant of this virus.

This article has been cited by other articles:

• Avvakumov, N., Wheeler, R., D'Halluin, J. C., Mymryk, J. S. (2002). Comparative Sequence Analysis of the Largest E1A Proteins of Human and Simian Adenoviruses. J. Virol. 76: 7968-7975 [Abstract] [Full Text]  
• Meyers, C., Bromberg-White, J. L., Zhang, J., Kaupas, M. E., Bryan, J. T., Lowe, R. S., Jansen, K. U. (2002). Infectious Virions Produced from a Human Papillomavirus Type 18/16 Genomic DNA Chimera. J. Virol. 76: 4723-4733 [Abstract] [Full Text]  
• Thomas, D. L., Shin, S., Jiang, B. H., Vogel, H., Ross, M. A., Kaplitt, M., Shenk, T. E., Javier, R. T. (1999). Early Region 1 Transforming Functions Are Dispensable for Mammary Tumorigenesis by Human Adenovirus Type 9. J. Virol. 73: 3071-3079 [Abstract] [Full Text]  
• Brockmann, D., Bury, C., Kröner, G., Kirch, H.-C., Esche, H. (1995). Repression of the c-Jun trans-Activation Function by the Adenovirus Type 12 E1A 52R Protein Correlates with the Inhibition of Phosphorylation of the c-Jun Activation Domain. J. Biol. Chem. 270: 10754-10763 [Abstract] [Full Text]